The U.S. Food and Drug Administration (FDA) has given the okay to an app designed to help clinicians diagnose autism in children, labeling it safe for use.
But it’s still unclear whether the technology is effective, researchers say, raising concerns that it could actually disrupt the standard diagnosis process and, in some cases, lead to delays in starting therapy. read more
